The chemistry of connection: dopamine, oxytocin and social hunger

September 29, 2026 · 28 min read

Huberman's episodes explain the hormones behind bonds and how social hunger shares circuits with food hunger, Robert Malenka describes the brain's social reward circuit, and Karen Parker explains why oxytocin trials disappointed. Understanding the biology explains why loneliness feels like a craving and why connection is a need, not a luxury.

The insight in about three minutes.

Loneliness feels like a craving because, in the brain, it is one. Across five conversations, the need for other people is described as running on the same machinery as hunger, thirst and warmth. Connection is no more a luxury than eating is.

Andrew Huberman describes a social thermostat, drawing on work from Kay Tye's lab. When we get less contact than we are used to, a small cluster of dopamine neurons fires and pushes us to seek people, as hunger pushes us toward a meal. Dopamine, he stresses, is about pursuit, not pleasure. In a human study, ten hours of isolation made people crave both company and food, and ten hours of fasting raised social craving as well as hunger. Short isolation makes us reach out. Chronic isolation does the opposite: stress hormones stay high, people grow irritable, and reconnecting gets harder. He also redefines introverts as people who are filled up by less contact, and separates that from isolation. He calls oxytocin the key hormone of bonding, slower and longer lasting, and describes healthy bonds as moving between dopamine-driven adventure and serotonin-driven calm.

Stanford's Robert Malenka shows that friendship runs through the same reward circuit as food and drugs. He calls the idea that dopamine simply equals pleasure "a gross oversimplification" and separates wanting from liking, a split that also describes relationships you crave without enjoying. His lab found that oxytocin boosts serotonin release in this circuit, and he insists these chemicals never work alone. Context matters too: the same person can be craved in the morning and unwelcome by night. He compares checking messages to a mouse pressing a lever.

Karen Parker, also at Stanford, explains why oxytocin has mostly disappointed as a treatment. Early small studies looked promising, but a large autism trial found no benefit. She says the molecule is fragile, autism is not one thing, and timing may matter. Her turning point was asking, "why are we looking in blood?" In spinal fluid, vasopressin, oxytocin's close sibling, tracked social ability in monkeys and children, and a small pilot trial of vasopressin improved children's social abilities. She stresses that it was small and a larger trial is under way.

They agree that the need is ancient, that the chemicals work as a team, and that the love hormone label is too simple. They differ on how much credit oxytocin deserves. Huberman gives it a central role, Malenka's results point to serotonin, and Parker's point to vasopressin.

The article sets limits. None of this makes the chemicals treatments. Parker warns against obtaining vasopressin on your own because of its effects on blood pressure, and MDMA remains illegal outside trials. Anyone considering hormones, peptides or drugs for mood or social problems should talk to a qualified physician first. Much of the mechanism comes from animals, which is a guide, not proof.

What to do with it: answer loneliness quickly, before withdrawal sets in. Notice when you eat to fill a social gap. Match your social life to the amount of contact you need. Do things together, not only talk. Mix novelty with comforting routine. Make sure the phone adds to time in person and does not replace it. Keep your own ability to calm yourself.

This is the short form. The full insight has every expert's reasoning, their own words and the sources.